CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-12 | Rodman David Malcom Chief Medical Officer | Option exercise | +6,349 | $1.08 | $7K | 170,869 |
| 2025-03-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −6,349 | 115,880 | ||
| 2025-02-13 | Levy Adam Scott CFO and Secretary | Grant or award · Stock Option | +170,000 | 170,000 | ||
| 2025-02-13 | Rodman David Malcom Chief Medical Officer | Grant or award · Stock Option | +170,000 | 170,000 | ||
| 2025-02-13 | AKKARAJU SRINIVAS Director | Grant or award · Stock Option | +32,900 | 32,900 | ||
| 2025-02-13 | Slingsby Brian Taylor Director | Grant or award · Stock Option | +32,900 | 32,900 | ||
| 2025-02-13 | Slingsby Brian Taylor Director | Other disposition · Stock Option | −32,900 | 0 | ||
| 2025-02-13 | Slingsby Brian Taylor Director | Other acquisition · Stock Option | +32,900 | 32,900 | ||
| 2025-02-13 | DiRocco Derek Director | Grant or award · Stock Option | +32,900 | 32,900 | ||
| 2025-02-13 | Gold Alexander M Director | Grant or award · Stock Option | +32,900 | 32,900 | ||
| 2025-02-13 | Congleton Jon Chief Executive Officer | Grant or award · Stock Option | +570,000 | 570,000 | ||
| 2025-02-13 | Karydas Daphne Director | Grant or award · Stock Option | +32,900 | 32,900 | ||
| 2025-02-13 | SBLENDORIO GLENN Director | Grant or award · Stock Option | +32,900 | 32,900 | ||
| 2025-02-13 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +32,900 | 32,900 | ||
| 2025-02-12 | Rodman David Malcom Chief Medical Officer | Option exercise | +6,348 | $1.08 | $7K | 164,520 |
| 2025-02-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −6,348 | 122,229 | ||
| 2025-01-13 | Levy Adam Scott CFO and Secretary | Sale 10b5-1 | −10,657 | $9.09 | $97K | 226,197 |
| 2025-01-13 | Levy Adam Scott CFO and Secretary | Sale 10b5-1 | −100 | $9.63 | $963 | 226,097 |
| 2025-01-13 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,018 | $0.54 | $3K | 151,823 |
| 2025-01-13 | Rodman David Malcom Chief Medical Officer | Option exercise | +6,349 | $1.08 | $7K | 158,172 |
Page 15 of 17 · 321 trades